The target for the vaccine (program) is (ensuring) 181 million people to achieve herd immunity and there are reserves, so that the number reaches over 370 million
Jakarta (ANTARA) - The Ministry of National Development Planning / National Development Planning Agency (PPN / Bappenas) has revealed that Indonesia will receive around 370 million doses of COVID-19 vaccines manufactured by different pharma companies by 2022. "The target for the vaccine (program) is (ensuring) 181 million people to achieve herd immunity and there are reserves, so that the number reaches over 370 million," Suharso Monoarfa, Minister of National Development Planning concurrently Head of Bappenas, said at an online press conference here on Monday.

Meanwhile, Bappenas deputy for economic affairs, Amalia Adininggar Widyasanti, provided further details on the plans for vaccine delivery, based on data discussed at the Committee for Handling COVID-19 and National Economic Recovery (KPC-PEN). Around 116 million doses of the Sinovac vaccine are expected to arrive in Indonesia by 2021, she said.

Novavax has confirmed it will ship about 52 million vaccine doses in 2021, she added.

Indonesia is in the process of ordering doses from Pfizer, she informed adding, 45 million doses of the Pfizer vaccine are expected to arrive in 2021. Another 12 million doses from Covax and 50 million doses from AstraZeneca are also being ordered, Widyasanti said.

"If all three brands can [fulfill the] order, there will be 275 million vaccines that we will get in 2021," she said at a press conference that took place in Bali.

Meanwhile, in 2022, shipments will continue based on confirmed orders, namely from Sinovac and Novavax, both of whom are expected to dispatch around 87 million vaccine doses.

Earlier, Coordinating Minister for Economic Affairs, Airlangga Hartarto, had revealed that the government has prepared a budget of Rp73 trillion for vaccine procuremen

Meanwhile, Minister of Finance, Sri Mulyani Indrawati, said the state has already allocated a budget for vaccine procurement, which is estimated to reach Rp54.44 trillion. A total of Rp18 trillion in reserves and the remaining budget in the national economic recovery program for 2020, which has not been absorbed will be redirected into the new budget, she added. (INE)


Related news: Year ender - Not the time to let guard down on COVID, govt warns

Related news: Task Force ensures regional readiness to distribute COVID-19 vaccines



EDITED BY INE

Translator: Dewa Wiguna, Azis Kurmala
Editor: Fardah Assegaf
Copyright © ANTARA 2020